TCTR20200308001已完成4 期
Amoxicillin/clavulanate tablet (625mg) plus amoxicillin capsule (500mg) is not inferior to amoxicillin/clavulanate tablet (1000mg) for treating acute bacterial rhinosinusitis
Ratchadapiseksompotch Fund, Faculty of Medicine, Chulalongkorn University0 个研究点目标入组 56 人开始时间: 2020年3月8日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 56
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 75 Years（—）
- 性别
- All
入选标准
- •(1) patients with ABRS using diagnostic criteria recommended by the guideline of Infectious Diseases Society of America IDSA2012 who has age between 18-75 years.
排除标准
- •(1) patients identified as having ABRS with problems including orbital cellulitis, sub-periosteal abscess, orbital abscess, intracranial disorders, brain swelling, subdural empyema and meningitis, facial osteomyelitis, and clotting of the cavernous sinus and cortical vein (2) who had received amoxicillin/clavulanate within the past 3 months (3) patients with a history of hypersensitivity drugs used in the study (4) patients who are pregnant (5) patient who are breastfeeding (6) Patient who had a history of sinus surgery before.
研究者
相似试验
进行中（未招募）
1 期
Amoxicillin-clavulanate alone or in combination with Ciprofloxacin in Low-Risk Febrile Neutropenic adult Patients: A Prospective, Double-blind, Randomized, Non-InferiorityMulticenter, Phase III Clinical TrialMedDRA version: 20.0Level: LLTClassification code 10076734Term: Chemotherapy induced neutropeniaSystem Organ Class: 100000004851EUCTR2020-003159-13-FRCHU DE POITIERS360
进行中（未招募）
1 期
Alternative antibiotics to multidrug-resistant UTIsrinary tract infection and/or bacteremia caused by extended spectrum beta-lactamases-producing EnterobacteralesEUCTR2020-005738-13-SERegion Skåne280
撤回
2 期
ebulising Amoxicillin-Clavulanic Acid in Patients with COPD (NACAP)COPD10024970NL-OMON36305Medisch Spectrum Twente30
已完成
不适用
Treatment of Community Acquired Pneumonia in childreCTRI/2019/01/017124DR AMRIT AGARWA104
招募中
1 期
Amoxicillin alone versus amoxicillin/clavulanate for community-acquired pneumonia in patients aged 65 years or older, and hospitalized in a non-intensive care unit ward: a non-inferiority randomized controlled trial _ CAPTAICTIS2023-503645-63-00Centre Hospitalier Universitaire De Nantes326